How many insider trades does FilingIQ track for HQL?

FilingIQ tracks 89 Form 4 insider transactions for HQL (abrdn Life Sciences Investors), covering filings from Jun 29, 2015 onwards. 1 of those were filed in the last 90 days.

Are HQL insiders net buyers or net sellers?

Across the full Form 4 history for HQL, 50 transactions (56%) were open-market purchases and 39 (44%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does HQL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is HQL in?

abrdn Life Sciences Investors (HQL) is classified in the Financial Services sector, specifically Asset Management, with a current market capitalisation of $484.53M.

HQL insider trading

NYSE Financial Services

abrdn Life Sciences Investors — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

56% / 44%

Market cap

$484.53M

About abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

HQL insider activity at a glance

FilingIQ has scored 89 insider transactions for HQL since Jun 29, 2015. The most recent filing in our index is dated Jul 16, 2026.

Across the full history, 50 open-market purchases and 39 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on HQL insider trades is 50.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live HQL trades on FilingIQ Raw filings on SEC EDGAR

Other Financial Services tickers with recent insider activity

WAL 229

WESTERN ALLIANCE BANCORPORATION

CRCL 222

Circle Internet Group, Inc.

CACC 196

CREDIT ACCEPTANCE CORP

MIAX 168

MIAMI INTERNATIONAL HOLDINGS, INC.

LIFE 119

Ethos Technologies Inc.

MFG 115

MIZUHO FINANCIAL GROUP INC

HOOD 107

Robinhood Markets, Inc.

SLQT 103

SelectQuote, Inc.

Politicians who have traded HQL

Grijalva, Raúl M.

U.S. Rep. , AZ · 117 trades

Frequently asked

How many insider trades does FilingIQ track for HQL?: FilingIQ tracks 89 Form 4 insider transactions for HQL (abrdn Life Sciences Investors), covering filings from Jun 29, 2015 onwards. 1 of those were filed in the last 90 days.
Are HQL insiders net buyers or net sellers?: Across the full Form 4 history for HQL, 50 transactions (56%) were open-market purchases and 39 (44%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does HQL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is HQL in?: abrdn Life Sciences Investors (HQL) is classified in the Financial Services sector, specifically Asset Management, with a current market capitalisation of $484.53M.

Methodology & sources

Every HQL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.